eFFECTOR Therapeutics Doses First Patient with COVID-19 in Phase 1b Clinical Trial Evaluating Zotatifin as a Host-Targeted Antiviral Agent Portfolio News / Karina Tin July 22, 2021 eFFECTOR Therapeutics Doses First Patient with COVID-19 in Phase 1b Clinical Trial Evaluating Zotatifin as a Host-Targeted Antiviral Agent Read More »
NGM Announces Completion of Enrollment in Phase 2 CATALINA Study of NGM621 in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration Portfolio News / Karina Tin July 22, 2021 NGM Announces Completion of Enrollment in Phase 2 CATALINA Study of NGM621 in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration Read More »
MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology Portfolio News / Karina Tin July 15, 2021 MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology Read More »
Ribon Therapeutics Secures $65 Million Financing Portfolio News / Karina Tin July 14, 2021 Ribon Therapeutics Secures $65 Million Financing Read More »
Escient Pharmaceuticals Announces Positive Results From Phase 1 Study Of EP547, An MrgprX4-Targeted Oral Therapy For Cholestatic And Uremic Pruritus Portfolio News / Karina Tin July 14, 2021 Escient Pharmaceuticals Announces Positive Results From Phase 1 Study Of EP547, An MrgprX4-Targeted Oral Therapy For Cholestatic And Uremic Pruritus Read More »
Nurix Therapeutics Reports Second Quarter Fiscal 2021 Financial Results and Provides a Corporate Update Portfolio News / Karina Tin July 13, 2021 Nurix Therapeutics Reports Second Quarter Fiscal 2021 Financial Results and Provides a Corporate Update Read More »
Tenaya Therapeutics Unveils Preclinical Research Supporting Product Candidate for Rare and Prevalent Heart Disease Indications at ESC Heart Failure 2021 Portfolio News / Karina Tin July 12, 2021 Tenaya Therapeutics Unveils Preclinical Research Supporting Product Candidate for Rare and Prevalent Heart Disease Indications at ESC Heart Failure 2021 Read More »
Surrozen Presents New Data Demonstrating Superior Activity of SZN-1326 in Preclinical Inflammatory Bowel Disease Models at 16th Congress of the European Crohn’s and Colitis Organisation (ECCO) Portfolio News / Karina Tin July 9, 2021 Surrozen Presents New Data Demonstrating Superior Activity of SZN-1326 in Preclinical Inflammatory Bowel Disease Models at 16th Congress of the European Crohn’s and Colitis Organisation (ECCO) Read More »
NGM Bio Announces Initiation of Phase 1/2 Clinical Study of NGM707 for the Treatment of Advanced Solid Tumors Portfolio News / Karina Tin July 7, 2021 NGM Bio Announces Initiation of Phase 1/2 Clinical Study of NGM707 for the Treatment of Advanced Solid Tumors Read More »
NGM Amends Collaboration with Merck to Focus Primarily on Advancing Novel Medicines for Retinal and Cardiovascular and Metabolic (CVM) Diseases Portfolio News / Karina Tin July 1, 2021 NGM Amends Collaboration with Merck to Focus Primarily on Advancing Novel Medicines for Retinal and Cardiovascular and Metabolic (CVM) Diseases Read More »
